136 related articles for article (PubMed ID: 26675063)
1. Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics.
Niedzielski JS; Yang J; Stingo F; Martel MK; Mohan R; Gomez DR; Briere TM; Liao Z; Court LE
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):385-93. PubMed ID: 26675063
[TBL] [Abstract][Full Text] [Related]
2. Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers.
Niedzielski JS; Yang J; Mohan R; Titt U; Mirkovic D; Stingo F; Liao Z; Gomez DR; Martel MK; Briere TM; Court LE
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):1013-1020. PubMed ID: 29063837
[TBL] [Abstract][Full Text] [Related]
3. (18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.
Niedzielski JS; Yang J; Liao Z; Gomez DR; Stingo F; Mohan R; Martel MK; Briere TM; Court LE
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):670-8. PubMed ID: 27681764
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.
Bradley J; Deasy JO; Bentzen S; El-Naqa I
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1106-13. PubMed ID: 15001251
[TBL] [Abstract][Full Text] [Related]
5. A technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation-induced esophagitis.
Court LE; Tucker SL; Gomez D; Liao Z; Zhang J; Kry S; Dong L; Martel MK
J Appl Clin Med Phys; 2013 May; 14(3):4195. PubMed ID: 23652249
[TBL] [Abstract][Full Text] [Related]
6. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
[TBL] [Abstract][Full Text] [Related]
7. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
[TBL] [Abstract][Full Text] [Related]
8. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
Rodríguez N; Algara M; Foro P; Lacruz M; Reig A; Membrive I; Lozano J; López JL; Quera J; Fernández-Velilla E; Sanz X
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):810-7. PubMed ID: 18755556
[TBL] [Abstract][Full Text] [Related]
9. Early Prediction of Acute Esophagitis for Adaptive Radiation Therapy.
Alam SR; Zhang P; Zhang SY; Chen I; Rimner A; Tyagi N; Hu YC; Lu W; Yorke ED; Deasy JO; Thor M
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):883-892. PubMed ID: 33453309
[TBL] [Abstract][Full Text] [Related]
10. "Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics.
Kahn D; Zhou S; Ahn SJ; Hollis D; Yu X; D'Amico TA; Shafman TD; Marks LB
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):645-51. PubMed ID: 15936540
[TBL] [Abstract][Full Text] [Related]
11. The esophageal dose-volume parameters for predicting Grade I-II acute esophagitis correlated with weight loss and serum albumin decrease in lung cancer radiotherapy.
Kaymak Cerkesli ZA; Ozkan EE; Ozseven A
J Cancer Res Ther; 2021; 17(1):94-98. PubMed ID: 33723138
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
[TBL] [Abstract][Full Text] [Related]
13. Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
Zehentmayr F; Söhn M; Exeli AK; Wurstbauer K; Tröller A; Deutschmann H; Fastner G; Fussl C; Steininger P; Kranzinger M; Belka C; Studnicka M; Sedlmayer F
Radiat Oncol; 2015 May; 10():121. PubMed ID: 26018527
[TBL] [Abstract][Full Text] [Related]
14. Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer.
Mehmood Q; Sun A; Becker N; Higgins J; Marshall A; Le LW; Vines DC; McCloskey P; Ford V; Clarke K; Yap M; Bezjak A; Bissonnette JP
J Thorac Oncol; 2016 Feb; 11(2):213-21. PubMed ID: 26718880
[TBL] [Abstract][Full Text] [Related]
15. A Contralateral Esophagus-Sparing Technique to Limit Severe Esophagitis Associated With Concurrent High-Dose Radiation and Chemotherapy in Patients With Thoracic Malignancies.
Al-Halabi H; Paetzold P; Sharp GC; Olsen C; Willers H
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):803-10. PubMed ID: 26104934
[TBL] [Abstract][Full Text] [Related]
16. Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy.
Yuan ST; Brown RK; Zhao L; ten Haken RK; Gross M; Cease KB; Schipper M; Stanton P; Yu J; Kong FM
Radiat Oncol; 2014 Jan; 9(1):37. PubMed ID: 24467939
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predictors of severe acute esophagitis and subsequent esophageal stricture in patients treated with accelerated hyperfractionated chemoradiation for limited-stage small cell lung cancer.
Grant JD; Shirvani SM; Tang C; Juloori A; Rebueno NC; Allen PK; Chang JY
Pract Radiat Oncol; 2015; 5(4):e383-91. PubMed ID: 25731965
[TBL] [Abstract][Full Text] [Related]
19. Model development of dose and volume predictors for esophagitis induced during chemoradiotherapy for lung cancer as a step towards radiobiological treatment planning.
He R; Duggar WN; Yang CC; Vijayakumar S
BMC Pulm Med; 2023 Oct; 23(1):379. PubMed ID: 37814254
[TBL] [Abstract][Full Text] [Related]
20. Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer.
Everitt S; Duffy M; Bressel M; McInnes B; Russell C; Sevitt T; Ball D
Radiat Oncol; 2016 Feb; 11():20. PubMed ID: 26864559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
